Form 4: ResMed Executive Ghoshal Exercises Options and Sells Shares Under 10b5-1 Plan

Kaushik Ghoshal, Chief Commercial Officer, SaaS at ResMed, executed stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Summary

• On October 11, 2024, Kaushik Ghoshal, Chief Commercial Officer, SaaS at ResMed, exercised options to acquire 4,260 shares of ResMed common stock at a price of $101.64.
• Simultaneously, Ghoshal sold 4,260 shares of ResMed common stock at a price of $238.48.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on April 29, 2024.
• Following these transactions, Ghoshal directly owns 21,788 shares of ResMed common stock.

Sentiment

Score: 5

Explanation: The document describes routine executive stock transactions under a pre-arranged plan, indicating a neutral sentiment.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often governed by Rule 10b5-1 plans to avoid insider trading allegations. These plans allow insiders to sell shares at predetermined times and prices.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
• Rule 10b5-1 plans are a standard practice among corporate executives to manage their stock holdings and avoid potential insider trading concerns.
• The vesting schedule of 1/3 per year for the options is a typical vesting arrangement.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the impact is likely to be minimal given the relatively small number of shares involved.

Key Dates